{"gene":"PUM2","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":2001,"finding":"PUM2 contains a C-terminal PUM-HD RNA-binding domain and binds a consensus RNA sequence (PBE: UGUANAUARNNNNBBBBSCCS) with high affinity (Kd ~6.5 nM), as determined by SELEX with recombinant PUM2 PUM-HD protein.","method":"SELEX (iterative amplification-selection), recombinant protein binding assay","journal":"RNA","confidence":"High","confidence_rationale":"Tier 1 — in vitro binding assay with purified recombinant domain, quantitative Kd measurement","pmids":["11780640"],"is_preprint":false},{"year":2005,"finding":"Human PUM2 specifically binds the Drosophila Nanos Response Element (NRE); single nucleotide changes abolish binding. PUM2 and DAZL co-immunoprecipitate and can bind the same RNA targets, including the 3'UTR of human SDAD1 mRNA.","method":"Co-immunoprecipitation, RNA binding assays, mutational analysis of NRE","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 1-2 — direct binding assays with mutagenesis plus reciprocal co-IP","pmids":["15607425"],"is_preprint":false},{"year":2005,"finding":"Human BOULE (BOL) forms homodimers and interacts with PUM2. BOL and PUM2 form a complex on a subset of PUM2 RNA targets distinct from targets bound by PUM2/DAZL, indicating that protein cofactors determine which RNA targets are bound by PUM2.","method":"Co-immunoprecipitation, domain mapping, RNA binding assays","journal":"Molecular reproduction and development","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal co-IP with domain mapping, single lab","pmids":["15806553"],"is_preprint":false},{"year":2005,"finding":"PUM2 binds the 3'UTR of P2P-R mRNA via PUM2-binding elements (one perfect and two near-perfect PBEs), as confirmed by PUM2 pull-down combined with RT-PCR, suggesting PUM2-mediated translational regulation of P2P-R.","method":"RNA pull-down, RT-PCR","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 3 — single pull-down method, moderate mechanistic follow-up","pmids":["15617101"],"is_preprint":false},{"year":2011,"finding":"PUM2 physically binds the D-box of Aurora-A kinase, protects Aurora-A from APC/C(Cdh1)-mediated ubiquitination and proteasomal degradation, and enhances Aurora-A kinase activity. In interphase, PUM2 is cytoplasmic and acts as a translational repressor; in mitosis, PUM2 translocates to centrosomes to stabilize and activate Aurora-A.","method":"Co-immunoprecipitation, ubiquitination assay, kinase activity assay, overexpression/depletion, immunofluorescence localization","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal assays (co-IP, ubiquitination, kinase activity, localization) in single study","pmids":["21589936"],"is_preprint":false},{"year":2019,"finding":"PUM2 inhibits translation of Mff (mitochondrial fission factor) mRNA, impairing mitochondrial fission and mitophagy. PUM2 levels increase with aging; CRISPR/Cas9-mediated Pum2 knockout in elderly mouse muscles enhances mitochondrial fission and mitophagy, improving mitochondrial quality control.","method":"Multi-omics, translational repression assays, CRISPR/Cas9 knockout in mice, cross-species (C. elegans puf-8 knockdown)","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 — multi-omics plus in vivo genetic KO with defined molecular and cellular phenotype, replicated cross-species","pmids":["30642763"],"is_preprint":false},{"year":2019,"finding":"PUM1 and PUM2 repress translation of Cdkn1b (p27) by binding PBEs in its 3'UTR, promoting G1-S transition and cell proliferation, thereby controlling mouse body and organ size. Auto-regulatory and reciprocal post-transcriptional repression between Pum1 and Pum2 contributes to tissue-specific size control.","method":"Reporter assays (3'UTR luciferase), genetic null mouse models, epistasis (Cdkn1b deficiency rescue), cell proliferation assays","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1-2 — reporter assays plus multiple genetic null mouse models and epistasis","pmids":["30811992"],"is_preprint":false},{"year":2019,"finding":"Pum2 is restricted to the soma of developing neurons and retains PBE-containing mRNAs in the cell body, preventing their transport into axons. Pum2 knockdown causes PBE-containing mRNAs to appear and be translated in axons, and Pum2-deficient neurons exhibit axon growth, branching, and regeneration defects.","method":"Knockdown (shRNA), live-cell imaging, mRNA localization assays, in vivo axon branching analysis, axon regeneration assay","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 — KD with direct localization experiment tied to functional consequence, replicated in vivo and in vitro","pmids":["31606248"],"is_preprint":false},{"year":2019,"finding":"PUM2 directly binds the 3'UTR of JAK2 and RUNX2 mRNAs and represses their translation. PUM2 depletion blocks MSC adipogenesis and enhances osteogenesis; Pum2 CRISPR knockdown in zebrafish inhibits lipid accumulation and induces bone formation.","method":"3'UTR reporter assays, RNA immunoprecipitation, CRISPR/Cas9 knockdown in zebrafish, differentiation assays","journal":"Journal of cellular physiology","confidence":"High","confidence_rationale":"Tier 1-2 — direct binding assay plus in vivo genetic model with defined phenotype","pmids":["31595981"],"is_preprint":false},{"year":2019,"finding":"PUM2 cooperativity in binding multiple PBE sites is mediated by RNA structure rather than direct protein-protein interactions; binding of one PUM2 molecule redistributes RNA conformational states to modulate access to additional PBE sites (positive or negative cooperativity depending on structural stability).","method":"Equilibrium binding measurements on 68 synthetic RNAs, statistical mechanical modeling, two-temperature analysis","journal":"RNA","confidence":"High","confidence_rationale":"Tier 1 — quantitative in vitro binding assays across 68 RNA constructs with modeling","pmids":["30914482"],"is_preprint":false},{"year":2018,"finding":"PUM2 (but not PUM1) requires PBEs for repression of SIAH1 3'UTR-dependent reporter expression, whereas PUM1 exhibits PBE-independent repression. NANOS3 directly binds SIAH1 3'UTR independently of PBEs or the PUF domain, cooperating with PUM proteins in mRNA regulation.","method":"Luciferase reporter assays, EMSA, mutational analysis of PBEs","journal":"Cellular and molecular life sciences","confidence":"Medium","confidence_rationale":"Tier 1-2 — direct binding (EMSA) plus reporter mutagenesis, single lab","pmids":["30269240"],"is_preprint":false},{"year":2019,"finding":"PUM2 competitively binds to STARD13 3'UTR with miR-590-3p and miR-9, as shown by RIP-seq and luciferase reporter assays. PUM2 overexpression inhibits osteosarcoma cell proliferation, migration, and stemness via this mechanism.","method":"RNA immunoprecipitation combined with RNA sequencing, luciferase reporter assay, cell functional assays","journal":"Cell proliferation","confidence":"Medium","confidence_rationale":"Tier 2-3 — RIP-seq plus reporter assay, single lab","pmids":["30084199"],"is_preprint":false},{"year":2020,"finding":"SUMOylation of PUM2 by UBE2I/SUMO2/3 decreases PUM2 protein stability and reduces PUM2's inhibitory effect on CEBPD mRNA, leading to upregulation of CEBPD and downstream DSG2, which promotes glioma vasculogenic mimicry.","method":"Co-immunoprecipitation, immunofluorescence, RIP assay, ChIP assay, luciferase assay, cell invasion/migration assays","journal":"Clinical and translational medicine","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP for SUMOylation plus RIP for RNA binding, single lab with multiple methods","pmids":["32997416"],"is_preprint":false},{"year":2020,"finding":"Pum2 mediates decay of Sirt1 mRNA via binding to two PBEs in the Sirt1 3'UTR. Pum2-mediated Sirt1 mRNA decay promotes LKB1 acetylation and represses AMPK pathway activity, contributing to cardiomyocyte apoptosis in hypoxia/reoxygenation injury.","method":"3'UTR binding assay, overexpression/knockdown, Western blot for AMPK pathway, apoptosis assays","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct binding mapped to PBEs, pathway functional readout, single lab","pmids":["32437714"],"is_preprint":false},{"year":2020,"finding":"Pum2 overexpression reduces Mff protein levels (without affecting mRNA) and preserves mitochondrial homeostasis in acute ischemic kidney injury, confirming the Pum2-Mff post-transcriptional axis in renal tubular cells.","method":"Western blot, overexpression in murine ischemia model, mitochondrial functional assays","journal":"Cell biology and toxicology","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo genetic manipulation with defined molecular and cellular phenotype, single lab","pmids":["31993882"],"is_preprint":false},{"year":2022,"finding":"Pum2 directly interacts with and affects the translation (but not mRNA levels or splicing) of Sox5, Bcl11b/Ctip2, and Rorβ mRNAs in mouse neocortical neurons, regulating area-specific cytoarchitecture and subcerebral connectivity.","method":"Transfection of primary neurons, in utero electroporation, retrograde labeling, single-molecule FISH, qRT-PCR, Pum2-Emx1-Cre conditional KO mice","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1-2 — direct binding plus in vivo conditional KO with cellular and circuit-level phenotype, multiple orthogonal methods","pmids":["35262486"],"is_preprint":false},{"year":2023,"finding":"PUM2 directly binds DLX5 mRNA and represses its translation; PUM2 knockdown upregulates DLX5 expression and enhances osteogenic differentiation of mesenchymal stem cells.","method":"RNA immunoprecipitation, 3'UTR reporter assay, osteogenic differentiation assay, rat calvarial defect model","journal":"Journal of biomedical science","confidence":"Medium","confidence_rationale":"Tier 2 — direct RIP plus reporter assay with in vivo functional model, single lab","pmids":["37088847"],"is_preprint":false},{"year":2020,"finding":"PUM2 and PUM1 form distinct RNP regulatory networks in human male germ cells (TCam-2), associating with different protein cofactors (identified by mass spectrometry) and partially non-overlapping mRNA targets (identified by RIP-Seq), indicating functional divergence between paralogs.","method":"RIP-Seq, RNA-Seq, mass spectrometry-based interactome profiling","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 — global MS interactome plus RIP-Seq, single lab","pmids":["32316190"],"is_preprint":false},{"year":2019,"finding":"LncRNA circ_0075932 binds directly to PUM2 protein; PUM2 positively regulates AuroraA kinase, which activates the NF-κB pathway to promote inflammation and apoptosis in dermal keratinocytes downstream of adipocyte-derived exosomes.","method":"RNA-protein direct binding assay, siRNA knockdown, NF-κB pathway assays, cell apoptosis/inflammation assays","journal":"Biochemical and biophysical research communications","confidence":"Low","confidence_rationale":"Tier 3 — single binding assay, pathway inference from knockdown","pmids":["30824182"],"is_preprint":false},{"year":2021,"finding":"PUM2 mediates packaging of miR-130a into exosomes in cancer-associated fibroblasts; overexpression/knockdown of PUM2 correspondingly promotes/inhibits exosomal miR-130a loading and xenograft tumor growth.","method":"Overexpression, knockdown, exosome isolation, miRNA quantification, xenograft mouse model","journal":"International journal of nanomedicine","confidence":"Low","confidence_rationale":"Tier 3 — functional assay without direct molecular mechanism for packaging","pmids":["33542625"],"is_preprint":false},{"year":2022,"finding":"PUM2 suppresses SIRT1 expression, which in turn inhibits SLC7A11 expression, thereby aggravating ferroptosis and neuroinflammation in cerebral ischemia-reperfusion injury.","method":"RT-qPCR, Western blot, knockdown in MCAO mouse model and OGD/R cell model, rescue assays","journal":"Molecular and cellular biochemistry","confidence":"Low","confidence_rationale":"Tier 3 — pathway placement by knockdown/rescue without direct binding validation for SIRT1 target","pmids":["35997855"],"is_preprint":false},{"year":2023,"finding":"PUM2 binds EFEMP1 mRNA via immunoprecipitation and promotes EFEMP1 expression (stabilization), inhibiting vascular smooth muscle cell phenotypic switching (proliferation/migration) and preventing aortic dissection in an Ang-II mouse model.","method":"Immunoprecipitation of RNA, Western blot, overexpression vectors, Ang-II mouse model, immunofluorescence","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct RNA-IP plus in vivo model, single lab","pmids":["37062520"],"is_preprint":false},{"year":2024,"finding":"PUM2 facilitates degradation of NEDD4 mRNA by binding its 3'UTR, which prevents NEDD4-mediated ubiquitination and degradation of PTEN, thereby increasing PTEN levels and promoting chondrocyte ferroptosis through the Nrf2/HO-1 pathway.","method":"RNA immunoprecipitation, 3'UTR binding assay, Western blot, knockdown/overexpression, DMM mouse OA model","journal":"Environmental toxicology","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct RIP binding plus in vivo model and pathway rescue experiments, single lab","pmids":["38733337"],"is_preprint":false},{"year":2025,"finding":"SENP1 directly deSUMOylates PUM2 (confirmed by Ni2+-NTA pull-down and co-IP), thereby enhancing PUM2 stability and expression. Stabilized PUM2 binds the 3'UTR of NRF2 mRNA, reducing NRF2 levels and diminishing transcriptional activation of HK1 and GLUT1, reducing glycolytic function in astrocytes.","method":"Ni2+-NTA agarose pull-down, co-immunoprecipitation, 3'UTR binding assay, APP/PS1 transgenic mouse model, knockdown rescue","journal":"Cell biology and toxicology","confidence":"Medium","confidence_rationale":"Tier 1-2 — direct deSUMOylation confirmed biochemically plus RNA binding and in vivo genetic model, single lab","pmids":["39794619"],"is_preprint":false},{"year":2025,"finding":"PUM2-mediated repression of target mRNAs requires the CCR4-NOT deadenylase and is dependent on poly(A)-binding proteins PABPC1 and PABPC4; PUM2 associates with PABPCs, and increasing PABPC concentration inhibits PUM activity by stabilizing poly(A) tails.","method":"mRNA stability assays, co-immunoprecipitation of PUM with PABPCs, deadenylase requirement assays, PABPC titration experiments","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 1-2 — multiple biochemical assays in single preprint study, not yet peer-reviewed","pmids":["bio_10.1101_2025.10.02.680050"],"is_preprint":true},{"year":2025,"finding":"PUM2 directly binds conserved Pumilio response elements (PREs) in SARS-CoV-2 transcripts, as shown by interactome data and PRE analysis, but neither PUM1 nor PUM2 affects progeny virion production.","method":"High-throughput interactome analysis, PRE mapping, PUM depletion and viral replication assays","journal":"The Journal of general virology","confidence":"Medium","confidence_rationale":"Tier 2 — direct RNA binding supported by interactome data and functional viral assays, single study","pmids":["40956600"],"is_preprint":false},{"year":2024,"finding":"PUM2 directly binds the 3'UTR of FOXO3 mRNA and inhibits its expression, promoting chondrocyte apoptosis in osteoarthritis.","method":"RNA immunoprecipitation, RNA pull-down, luciferase reporter, overexpression/knockdown, flow cytometry","journal":"Heliyon","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct binding by multiple assays with functional readout, single lab","pmids":["38356524"],"is_preprint":false},{"year":2025,"finding":"PUM2 suppresses stability of HDAC9 mRNA via direct binding (RIP and pull-down), attenuating HDAC9 expression and thereby reducing oxidative stress and promoting autophagy in diabetic contrast-induced acute kidney injury.","method":"RNA immunoprecipitation, RNA pull-down, mRNA stability assay, overexpression/knockdown, mouse DM-CIAKI model","journal":"Diabetes & metabolism journal","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding by two methods plus in vivo model, single lab","pmids":["40930160"],"is_preprint":false},{"year":2025,"finding":"The lncRNA Norad sequesters Pum2 protein, reducing its ability to bind and repress Mff mRNA translation. After ischemia-reperfusion, decreased Pum2 levels and binding to Mff mRNA (alongside increased Norad-Pum2 binding) lead to increased Mff protein, mitochondrial fragmentation, and neuronal injury; Pum2 overexpression restores mitochondrial morphology and reduces infarct volume.","method":"RNA-protein binding assays, OGD/R cell model, MCAO/R mouse model, Pum2 overexpression via viral vector","journal":"Brain research","confidence":"Medium","confidence_rationale":"Tier 2 — RNA-protein binding plus in vivo model with mechanistic and functional readout, single lab","pmids":["39832611"],"is_preprint":false}],"current_model":"PUM2 is a sequence-specific RNA-binding protein (PUF family) that uses its C-terminal PUM-HD domain to bind Pumilio-binding elements (PBEs: UGUANAUA) in 3'UTRs of target mRNAs, recruiting the CCR4-NOT deadenylase complex (dependent on PABPC1/4) to repress translation and/or promote mRNA decay of targets including Mff, Cdkn1b, Sirt1, JAK2, RUNX2, DLX5, and others; it is regulated post-translationally by SUMOylation (which reduces its stability) and deSUMOylation by SENP1 (which enhances it), and has a moonlighting mitotic role in which it physically associates with Aurora-A kinase at centrosomes to protect it from APC/C(Cdh1)-mediated degradation and enhance its kinase activity, while also shaping axonal transcriptomes by retaining PBE-containing mRNAs in the neuronal soma and controlling mitochondrial dynamics, body size, and stem cell differentiation through its translational repressor activity."},"narrative":{"teleology":[{"year":2001,"claim":"The fundamental RNA-recognition specificity of PUM2 was established: PUM2's C-terminal PUM-HD binds a defined PBE consensus (UGUANAUA) with nanomolar affinity, defining it as a sequence-specific post-transcriptional regulator.","evidence":"SELEX with recombinant PUM2 PUM-HD and quantitative binding (Kd ~6.5 nM)","pmids":["11780640"],"confidence":"High","gaps":["No endogenous mRNA targets were identified at this stage","No mechanism of repression (translational vs. decay) was determined"]},{"year":2005,"claim":"PUM2 was shown to bind biologically relevant RNA targets (NRE, SDAD1 3′UTR) and to operate with distinct protein cofactors (DAZL, BOULE) that determine target selectivity, establishing PUM2 as a combinatorial RNP regulator rather than a standalone factor.","evidence":"Co-immunoprecipitation, RNA binding assays with mutagenesis, and domain mapping in human cell extracts","pmids":["15607425","15806553"],"confidence":"High","gaps":["How cofactors alter RNA target selection was not mechanistically resolved","In vivo significance of PUM2–DAZL and PUM2–BOULE complexes was not tested"]},{"year":2011,"claim":"A non-canonical, RNA-independent role was discovered: PUM2 physically associates with Aurora-A kinase at centrosomes during mitosis, protects it from APC/C(Cdh1)-mediated degradation, and enhances its kinase activity, revealing a moonlighting function beyond translational repression.","evidence":"Co-IP, ubiquitination assays, kinase activity assays, and immunofluorescence localization in human cells","pmids":["21589936"],"confidence":"High","gaps":["Whether PUM2's RNA-binding and Aurora-A stabilization functions are coordinated or independent was not resolved","Structural basis of PUM2–D-box interaction was not determined"]},{"year":2019,"claim":"PUM2 was established as a key post-transcriptional repressor controlling mitochondrial dynamics (via Mff), cell cycle/body size (via Cdkn1b), mesenchymal stem cell fate (via JAK2/RUNX2), and neuronal architecture (via somatic mRNA retention), demonstrating broad physiological relevance across tissues and organisms.","evidence":"CRISPR KO mice (Mff target), genetic null mouse models with epistasis (Cdkn1b), 3′UTR reporters and zebrafish knockdown (JAK2/RUNX2), shRNA knockdown with mRNA localization imaging and in vivo axon analysis (neuronal soma retention)","pmids":["30642763","30811992","31595981","31606248"],"confidence":"High","gaps":["The deadenylase/decay machinery recruited by PUM2 was not yet identified","How PUM2 physically retains mRNAs in the soma vs. repressing translation was not mechanistically distinguished"]},{"year":2019,"claim":"Cooperativity in PUM2 binding to multi-PBE targets was shown to be RNA-structure-mediated rather than protein–protein-mediated, revealing that conformational redistribution of RNA upon PUM2 binding modulates access to additional sites.","evidence":"Quantitative equilibrium binding across 68 synthetic RNA constructs with statistical mechanical modeling","pmids":["30914482"],"confidence":"High","gaps":["Whether RNA-structure-mediated cooperativity operates on endogenous mRNAs in vivo was not tested","Effect on translational repression efficiency of cooperative vs. non-cooperative binding was not measured"]},{"year":2020,"claim":"Post-translational regulation of PUM2 by SUMOylation was identified: SUMO2/3 conjugation reduces PUM2 stability, diminishing its repressive capacity on targets such as CEBPD, linking SUMO signaling to PUM2-dependent gene regulation.","evidence":"Co-IP for SUMOylation, RIP for RNA binding, luciferase reporters in glioma cells","pmids":["32997416"],"confidence":"Medium","gaps":["The E3 SUMO ligase responsible was not identified","Whether SUMOylation directly alters RNA binding or only protein stability was not distinguished"]},{"year":2020,"claim":"PUM1 and PUM2 were shown to form distinct RNP complexes with partially non-overlapping interactomes and target mRNAs in human male germ cells, establishing functional divergence between the two paralogs.","evidence":"RIP-Seq and mass spectrometry interactome profiling in TCam-2 cells","pmids":["32316190"],"confidence":"Medium","gaps":["Functional consequences of paralog-specific targets were not tested","Whether divergence is conserved across tissues was not assessed"]},{"year":2022,"claim":"PUM2's role in cortical development was refined: it directly binds and translationally represses Sox5, Bcl11b/Ctip2, and Rorβ mRNAs in neocortical neurons, shaping area-specific cytoarchitecture and subcerebral projection neuron identity in vivo.","evidence":"Conditional Pum2 KO (Emx1-Cre), single-molecule FISH, retrograde tracing, in utero electroporation in mouse cortex","pmids":["35262486"],"confidence":"High","gaps":["Whether PUM2 controls these targets via deadenylation or translational initiation block was not determined","Interaction with other RNA-binding proteins in cortical progenitors was not mapped"]},{"year":2025,"claim":"SENP1-mediated deSUMOylation was identified as the counterbalancing mechanism that stabilizes PUM2, and the downstream functional consequence was mapped: stabilized PUM2 represses NRF2 mRNA, reducing glycolytic gene expression in astrocytes.","evidence":"Ni²⁺-NTA pull-down and co-IP for deSUMOylation, 3′UTR binding assay, APP/PS1 transgenic mouse model","pmids":["39794619"],"confidence":"Medium","gaps":["Whether SENP1-PUM2 axis operates globally or only in astrocytes is unknown","Quantitative relationship between SUMOylation state and PUM2 activity is not established"]},{"year":2025,"claim":"The effector mechanism of PUM2-mediated repression was identified: PUM2 recruits the CCR4-NOT deadenylase complex, and this repression requires and is antagonized by PABPC1/PABPC4 concentration, establishing PUM2 as a deadenylation-dependent repressor.","evidence":"(preprint) mRNA stability assays, co-IP of PUM2 with PABPCs, deadenylase requirement assays, PABPC titration","pmids":["bio_10.1101_2025.10.02.680050"],"confidence":"Medium","gaps":["Peer review pending","Whether all PUM2 targets are repressed via deadenylation or some use a deadenylation-independent mechanism was not resolved","Direct PUM2–CNOT subunit interaction was not mapped"]},{"year":2025,"claim":"The lncRNA NORAD was shown to act as a molecular sponge for PUM2, and ischemia-reperfusion shifts the NORAD–PUM2 equilibrium to de-repress Mff, causing mitochondrial fragmentation and neuronal injury — establishing NORAD as a physiological rheostat of PUM2 activity.","evidence":"RNA-protein binding assays, OGD/R cell model, MCAO/R mouse model with PUM2 viral overexpression","pmids":["39832611"],"confidence":"Medium","gaps":["Whether NORAD regulation of PUM2 is a general mechanism across tissues or restricted to ischemic neurons is not resolved","Stoichiometry of NORAD–PUM2 interaction in physiological conditions is unknown"]},{"year":null,"claim":"Major unresolved questions include the structural basis of PUM2-mediated CCR4-NOT recruitment, the mechanism by which PUM2 retains mRNAs in the neuronal soma versus canonical translational repression, and whether SUMOylation/deSUMOylation regulates PUM2 activity genome-wide or in a target-specific manner.","evidence":"","pmids":[],"confidence":"Low","gaps":["No cryo-EM or structural model of PUM2 in complex with CCR4-NOT","Mechanism of somatic mRNA retention versus translational silencing not distinguished","Genome-wide impact of SUMO cycling on PUM2 target repertoire unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[0,1,5,7,8,9,15,25]},{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[5,13,22,27]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[4,6]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[5,6,7,8,15,16]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[4,7]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[0,5,9,13,22,24,27]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[4,12,23,24]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[4,6]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[13,26]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[7,15]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[7,15,28]}],"complexes":[],"partners":["AURKA","DAZL","BOLL","PABPC1","PABPC4","SENP1","NANOS3"],"other_free_text":[]},"mechanistic_narrative":"PUM2 is a PUF-family sequence-specific RNA-binding protein that recognizes Pumilio-binding elements (PBEs/PREs; core motif UGUANAUA) in 3′UTRs of target mRNAs and represses their expression through translational inhibition and mRNA destabilization, thereby governing diverse processes including mitochondrial dynamics, cell cycle progression, body size control, stem cell differentiation, and neuronal circuit wiring. PUM2 represses targets such as Mff, Cdkn1b/p27, Sirt1, JAK2, RUNX2, DLX5, FOXO3, and NRF2 by recruiting the CCR4-NOT deadenylase complex in a PABPC1/PABPC4-dependent manner, while its target selectivity is modulated by cofactors including DAZL and BOULE and by the lncRNA NORAD, which sequesters PUM2 away from its mRNA targets [PMID:11780640, PMID:15607425, PMID:30642763, PMID:30811992, PMID:39832611, PMID:bio_10.1101_2025.10.02.680050]. PUM2 protein stability is regulated by SUMOylation (which promotes its degradation) and SENP1-mediated deSUMOylation (which stabilizes it), and PUM2 has a non-canonical mitotic role at centrosomes where it binds the D-box of Aurora-A kinase, protecting it from APC/C(Cdh1)-dependent ubiquitination and enhancing its kinase activity [PMID:32997416, PMID:39794619, PMID:21589936]. In neurons, PUM2 localizes to the soma and retains PBE-containing mRNAs in the cell body, controlling axonal transcriptome composition and thereby regulating axon growth, branching, and cortical cytoarchitecture [PMID:31606248, PMID:35262486]."},"prefetch_data":{"uniprot":{"accession":"Q8TB72","full_name":"Pumilio homolog 2","aliases":[],"length_aa":1066,"mass_kda":114.2,"function":"Sequence-specific RNA-binding protein that acts as a post-transcriptional repressor by binding the 3'-UTR of mRNA targets. Binds to an RNA consensus sequence, the Pumilio Response Element (PRE), 5'-UGUANAUA-3', that is related to the Nanos Response Element (NRE) (, PubMed:21397187). Mediates post-transcriptional repression of transcripts via different mechanisms: acts via direct recruitment of the CCR4-POP2-NOT deadenylase leading to translational inhibition and mRNA degradation (PubMed:22955276). Also mediates deadenylation-independent repression by promoting accessibility of miRNAs (PubMed:18776931, PubMed:22345517). Acts as a post-transcriptional repressor of E2F3 mRNAs by binding to its 3'-UTR and facilitating miRNA regulation (PubMed:22345517). Plays a role in cytoplasmic sensing of viral infection (PubMed:25340845). Represses a program of genes necessary to maintain genomic stability such as key mitotic, DNA repair and DNA replication factors. Its ability to repress those target mRNAs is regulated by the lncRNA NORAD (non-coding RNA activated by DNA damage) which, due to its high abundance and multitude of PUMILIO binding sites, is able to sequester a significant fraction of PUM1 and PUM2 in the cytoplasm (PubMed:26724866). May regulate DCUN1D3 mRNA levels (PubMed:25349211). May support proliferation and self-renewal of stem cells. Binds specifically to miRNA MIR199A precursor, with PUM1, regulates miRNA MIR199A expression at a postranscriptional level (PubMed:28431233)","subcellular_location":"Cytoplasm; Cytoplasmic granule; Cytoplasm, perinuclear region","url":"https://www.uniprot.org/uniprotkb/Q8TB72/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PUM2","classification":"Not Classified","n_dependent_lines":40,"n_total_lines":1208,"dependency_fraction":0.033112582781456956},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"PSMA5","stoichiometry":0.2},{"gene":"PSMG3","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/PUM2","total_profiled":1310},"omim":[{"mim_id":"617037","title":"NONCODING RNA ACTIVATED BY DNA DAMAGE; NORAD","url":"https://www.omim.org/entry/617037"},{"mim_id":"616167","title":"DCN1 DOMAIN-CONTAINING PROTEIN 3; DCUN1D3","url":"https://www.omim.org/entry/616167"},{"mim_id":"608226","title":"NANOS C2HC-TYPE ZINC FINGER 1; NANOS1","url":"https://www.omim.org/entry/608226"},{"mim_id":"607205","title":"PUMILIO RNA BINDING FAMILY MEMBER 2; PUM2","url":"https://www.omim.org/entry/607205"},{"mim_id":"607204","title":"PUMILIO RNA BINDING FAMILY MEMBER 1; PUM1","url":"https://www.omim.org/entry/607204"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Cytosol","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PUM2"},"hgnc":{"alias_symbol":["PUMH2","KIAA0235"],"prev_symbol":[]},"alphafold":{"accession":"Q8TB72","domains":[{"cath_id":"1.10.220","chopping":"709-800","consensus_level":"medium","plddt":96.2328,"start":709,"end":800},{"cath_id":"1.20.930","chopping":"962-1058","consensus_level":"medium","plddt":89.6295,"start":962,"end":1058}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TB72","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TB72-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TB72-F1-predicted_aligned_error_v6.png","plddt_mean":55.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PUM2","jax_strain_url":"https://www.jax.org/strain/search?query=PUM2"},"sequence":{"accession":"Q8TB72","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8TB72.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8TB72/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TB72"}},"corpus_meta":[{"pmid":"30642763","id":"PMC_30642763","title":"The RNA-Binding Protein PUM2 Impairs Mitochondrial Dynamics and Mitophagy During Aging.","date":"2019","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/30642763","citation_count":121,"is_preprint":false},{"pmid":"11780640","id":"PMC_11780640","title":"PUM2, a novel murine puf protein, and its consensus RNA-binding site.","date":"2001","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11780640","citation_count":94,"is_preprint":false},{"pmid":"12459267","id":"PMC_12459267","title":"Cloning and comparative sequence analysis of PUM1 and PUM2 genes, human members of the Pumilio family of RNA-binding proteins.","date":"2002","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/12459267","citation_count":77,"is_preprint":false},{"pmid":"34953631","id":"PMC_34953631","title":"The BMSC-derived exosomal lncRNA Mir9-3hg suppresses cardiomyocyte ferroptosis in ischemia-reperfusion mice via the Pum2/PRDX6 axis.","date":"2021","source":"Nutrition, metabolism, and cardiovascular diseases : NMCD","url":"https://pubmed.ncbi.nlm.nih.gov/34953631","citation_count":75,"is_preprint":false},{"pmid":"31993882","id":"PMC_31993882","title":"Pum2-Mff axis fine-tunes mitochondrial quality control in acute ischemic kidney injury.","date":"2020","source":"Cell biology and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/31993882","citation_count":69,"is_preprint":false},{"pmid":"15607425","id":"PMC_15607425","title":"Identification and characterization of RNA sequences to which human PUMILIO-2 (PUM2) and deleted in Azoospermia-like (DAZL) bind.","date":"2005","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/15607425","citation_count":68,"is_preprint":false},{"pmid":"33542625","id":"PMC_33542625","title":"CAFs-Derived Exosomal miRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging.","date":"2021","source":"International journal of nanomedicine","url":"https://pubmed.ncbi.nlm.nih.gov/33542625","citation_count":64,"is_preprint":false},{"pmid":"30824182","id":"PMC_30824182","title":"Circ_0075932 in adipocyte-derived exosomes induces inflammation and apoptosis in human dermal keratinocytes by directly binding with PUM2 and promoting PUM2-mediated activation of AuroraA/NF-κB pathway.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30824182","citation_count":54,"is_preprint":false},{"pmid":"12667987","id":"PMC_12667987","title":"Mouse Pum1 and Pum2 genes, members of the Pumilio family of RNA-binding proteins, show differential expression in fetal and adult hematopoietic stem cells and progenitors.","date":"2003","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/12667987","citation_count":54,"is_preprint":false},{"pmid":"30811992","id":"PMC_30811992","title":"Mammalian Pum1 and Pum2 Control Body Size via Translational Regulation of the Cell Cycle Inhibitor Cdkn1b.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/30811992","citation_count":46,"is_preprint":false},{"pmid":"31606248","id":"PMC_31606248","title":"Pum2 Shapes the Transcriptome in Developing Axons through Retention of Target mRNAs in the Cell Body.","date":"2019","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/31606248","citation_count":45,"is_preprint":false},{"pmid":"30084199","id":"PMC_30084199","title":"RNA-binding protein PUM2 suppresses osteosarcoma progression via partly and competitively binding to STARD13 3'UTR with miRNAs.","date":"2018","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/30084199","citation_count":41,"is_preprint":false},{"pmid":"15806553","id":"PMC_15806553","title":"Interaction of the conserved meiotic regulators, BOULE (BOL) and PUMILIO-2 (PUM2).","date":"2005","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/15806553","citation_count":33,"is_preprint":false},{"pmid":"32997416","id":"PMC_32997416","title":"SUMOylation of PUM2 promotes the vasculogenic mimicry of glioma cells via regulating CEBPD.","date":"2020","source":"Clinical and translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32997416","citation_count":33,"is_preprint":false},{"pmid":"35997855","id":"PMC_35997855","title":"PUM2 aggravates the neuroinflammation and brain damage induced by ischemia-reperfusion through the SLC7A11-dependent inhibition of ferroptosis via suppressing the SIRT1.","date":"2022","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35997855","citation_count":31,"is_preprint":false},{"pmid":"30909144","id":"PMC_30909144","title":"RNA binding protein PUM2 promotes the stemness of breast cancer cells via competitively binding to neuropilin-1 (NRP-1) mRNA with miR-376a.","date":"2019","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/30909144","citation_count":30,"is_preprint":false},{"pmid":"31646551","id":"PMC_31646551","title":"LncRNA TUG1 aggravates the progression of cervical cancer by binding PUM2.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31646551","citation_count":27,"is_preprint":false},{"pmid":"31595981","id":"PMC_31595981","title":"RNA-binding protein PUM2 regulates mesenchymal stem cell fate via repression of JAK2 and RUNX2 mRNAs.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31595981","citation_count":23,"is_preprint":false},{"pmid":"33398465","id":"PMC_33398465","title":"Circular RNA RBM33 contributes to cervical cancer progression via modulation of the miR-758-3p/PUM2 axis.","date":"2021","source":"Journal of molecular histology","url":"https://pubmed.ncbi.nlm.nih.gov/33398465","citation_count":22,"is_preprint":false},{"pmid":"32670859","id":"PMC_32670859","title":"Silencing SCAMP1-TV2 Inhibited the Malignant Biological Behaviors of Breast Cancer Cells by Interaction With PUM2 to Facilitate INSM1 mRNA Degradation.","date":"2020","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32670859","citation_count":21,"is_preprint":false},{"pmid":"21589936","id":"PMC_21589936","title":"A translational regulator, PUM2, promotes both protein stability and kinase activity of Aurora-A.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21589936","citation_count":18,"is_preprint":false},{"pmid":"30787206","id":"PMC_30787206","title":"PUM2 Promotes Glioblastoma Cell Proliferation and Migration via Repressing BTG1 Expression.","date":"2019","source":"Cell structure and function","url":"https://pubmed.ncbi.nlm.nih.gov/30787206","citation_count":17,"is_preprint":false},{"pmid":"30269240","id":"PMC_30269240","title":"PUM1 and PUM2 exhibit different modes of regulation for SIAH1 that involve cooperativity with NANOS paralogues.","date":"2018","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/30269240","citation_count":15,"is_preprint":false},{"pmid":"37088847","id":"PMC_37088847","title":"Downregulation of the RNA-binding protein PUM2 facilitates MSC-driven bone regeneration and prevents OVX-induced bone loss.","date":"2023","source":"Journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/37088847","citation_count":15,"is_preprint":false},{"pmid":"32437714","id":"PMC_32437714","title":"Pum2 mediates Sirt1 mRNA decay and exacerbates hypoxia/reoxygenation-induced cardiomyocyte apoptosis.","date":"2020","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/32437714","citation_count":14,"is_preprint":false},{"pmid":"30914482","id":"PMC_30914482","title":"Demonstration of protein cooperativity mediated by RNA structure using the human protein PUM2.","date":"2019","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/30914482","citation_count":14,"is_preprint":false},{"pmid":"15617101","id":"PMC_15617101","title":"P2P-R expression is genetically coregulated with components of the translation machinery and with PUM2, a translational repressor that associates with the P2P-R mRNA.","date":"2005","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15617101","citation_count":12,"is_preprint":false},{"pmid":"32316190","id":"PMC_32316190","title":"Characterization of RNP Networks of PUM1 and PUM2 Post-Transcriptional Regulators in TCam-2 Cells, a Human Male Germ Cell Model.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/32316190","citation_count":11,"is_preprint":false},{"pmid":"39183539","id":"PMC_39183539","title":"Melatonin alleviates hyperoxia-induced lung injury through elevating MSC exosomal miR-18a-5p expression to repress PUM2 signaling.","date":"2024","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/39183539","citation_count":10,"is_preprint":false},{"pmid":"38733337","id":"PMC_38733337","title":"PUM2 promoted osteoarthritis progression through PTEN-mediated chondrocyte ferroptosis by facilitating NEDD4 mRNA degradation.","date":"2024","source":"Environmental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/38733337","citation_count":9,"is_preprint":false},{"pmid":"35262486","id":"PMC_35262486","title":"Pum2 and TDP-43 refine area-specific cytoarchitecture post-mitotically and modulate translation of Sox5, Bcl11b, and Rorb mRNAs in developing mouse neocortex.","date":"2022","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/35262486","citation_count":8,"is_preprint":false},{"pmid":"36607285","id":"PMC_36607285","title":"Hyperglycemia-induced endothelial exosomes trigger trophoblast dysregulation and abnormal placentation through PUM2-mediated repression of SOX2.","date":"2023","source":"Human & experimental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/36607285","citation_count":7,"is_preprint":false},{"pmid":"37062520","id":"PMC_37062520","title":"PUM2 regulates the formation of thoracic aortic dissection through EFEMP1.","date":"2023","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/37062520","citation_count":6,"is_preprint":false},{"pmid":"36072004","id":"PMC_36072004","title":"RNA binding protein PUM2 promotes hepatocellular carcinoma proliferation and apoptosis via binding to the 3'UTR of BTG3.","date":"2022","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/36072004","citation_count":6,"is_preprint":false},{"pmid":"22220892","id":"PMC_22220892","title":"Spatial-temporal expression of pum1 and pum2 in medaka Oryzias latipes.","date":"2011","source":"Journal of fish biology","url":"https://pubmed.ncbi.nlm.nih.gov/22220892","citation_count":5,"is_preprint":false},{"pmid":"39979903","id":"PMC_39979903","title":"Potential of mir-299-5p to modulate LPS-induced inflammation and osteogenic differentiation of periodontal stem cells by targeting PUM2.","date":"2025","source":"BMC oral health","url":"https://pubmed.ncbi.nlm.nih.gov/39979903","citation_count":5,"is_preprint":false},{"pmid":"37747106","id":"PMC_37747106","title":"PUF-8, a C. elegans ortholog of the RNA-binding proteins PUM1 and PUM2, is required for robustness of the cell death fate.","date":"2023","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/37747106","citation_count":5,"is_preprint":false},{"pmid":"38249568","id":"PMC_38249568","title":"LncRNA 51325 Alleviates Bone Cancer Induced Hyperalgesia Through Inhibition of Pum2.","date":"2024","source":"Journal of pain research","url":"https://pubmed.ncbi.nlm.nih.gov/38249568","citation_count":3,"is_preprint":false},{"pmid":"40629911","id":"PMC_40629911","title":"IGF2BP2 binding to CPSF6 facilitates m6A-mediated alternative polyadenylation of PUM2 and promotes malignant progression in ovarian cancer.","date":"2025","source":"Clinical and translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40629911","citation_count":2,"is_preprint":false},{"pmid":"39832611","id":"PMC_39832611","title":"Disruption of the Pum2 axis Aggravates neuronal damage following cerebral Ischemia-Reperfusion in mice.","date":"2025","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/39832611","citation_count":2,"is_preprint":false},{"pmid":"40930160","id":"PMC_40930160","title":"PUM2 Lowers HDAC9 mRNA Stability to Improve Contrast-Induced Acute Kidney Injury through Attenuating Oxidative Stress and Promoting Autophagy.","date":"2025","source":"Diabetes & metabolism journal","url":"https://pubmed.ncbi.nlm.nih.gov/40930160","citation_count":2,"is_preprint":false},{"pmid":"38564095","id":"PMC_38564095","title":"Wnt/β-catenin Pathway Aggravates Renal Fibrosis by Activating PUM2 Transcription to Repress YME1L-mediated Mitochondrial Homeostasis.","date":"2024","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38564095","citation_count":2,"is_preprint":false},{"pmid":"38356524","id":"PMC_38356524","title":"RNA binding protein PUM2 promotes IL-1β-induced apoptosis of chondrocytes via regulating FOXO3 expression.","date":"2024","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/38356524","citation_count":2,"is_preprint":false},{"pmid":"39794619","id":"PMC_39794619","title":"SENP1 inhibits aerobic glycolysis in Aβ1-42-incubated astrocytes by promoting PUM2 deSUMOylation.","date":"2025","source":"Cell biology and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/39794619","citation_count":1,"is_preprint":false},{"pmid":"40887836","id":"PMC_40887836","title":"CircRERE promotes myocardial ischemia/reperfusion injury by increasing UHRF1 mRNA decay through targeting PUM2 to reduce Drp1 promoter methylation.","date":"2025","source":"Chinese medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/40887836","citation_count":1,"is_preprint":false},{"pmid":"36536516","id":"PMC_36536516","title":"RNA-binding protein PUM2 promotes T-cell acute lymphoblastic leukemia via competitively binding to RBM5 3'UTR with miR-28-5p.","date":"2023","source":"European journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/36536516","citation_count":1,"is_preprint":false},{"pmid":"40956600","id":"PMC_40956600","title":"PUM2 binds SARS-CoV-2 RNA and PUM1 mildly reduces viral RNA levels, but neither protein affects progeny virus production.","date":"2025","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/40956600","citation_count":1,"is_preprint":false},{"pmid":"37913857","id":"PMC_37913857","title":"Norad Competently Binds with Pum2 to Regulate Neuronal Apoptosis and Play a Neuroprotective Role After SAH in Mice.","date":"2023","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/37913857","citation_count":0,"is_preprint":false},{"pmid":"41694110","id":"PMC_41694110","title":"PUM2 knockdown regulates the expression and alternative splicing of genes associated with myocardial fibrosis in H9C2 cells.","date":"2026","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41694110","citation_count":0,"is_preprint":false},{"pmid":"39262254","id":"PMC_39262254","title":"MiR-495-3p promotes cardiac hypertrophy by targeting Pum2.","date":"2024","source":"Cellular and molecular biology (Noisy-le-Grand, France)","url":"https://pubmed.ncbi.nlm.nih.gov/39262254","citation_count":0,"is_preprint":false},{"pmid":"41856997","id":"PMC_41856997","title":"Loss of Pum2 exacerbates colitis by disrupting macrophage-epithelial crosstalk and promoting epithelial necroptosis.","date":"2026","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/41856997","citation_count":0,"is_preprint":false},{"pmid":"40666984","id":"PMC_40666984","title":"PUM2 binds SARS-CoV-2 RNA and PUM1 mildly reduces viral RNA levels, but neither protein affects progeny virus production.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40666984","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.11.27.691032","title":"Viral non-coding RNAs hijack host Pumilio proteins to regulate host transcripts","date":"2025-12-01","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.27.691032","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.10.11.681827","title":"PUMILIOs and m6A-ECT2/ECT3 share mRNA targets and exert opposing control over organogenesis","date":"2025-10-12","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.11.681827","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.10.02.680050","title":"Cytoplasmic poly-adenosine binding proteins modulate susceptibility of mRNAs to RNA-binding protein-directed decay","date":"2025-10-02","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.02.680050","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":29731,"output_tokens":6248,"usd":0.091456},"stage2":{"model":"claude-opus-4-6","input_tokens":9906,"output_tokens":3438,"usd":0.20322},"total_usd":0.294676,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"PUM2 contains a C-terminal PUM-HD RNA-binding domain and binds a consensus RNA sequence (PBE: UGUANAUARNNNNBBBBSCCS) with high affinity (Kd ~6.5 nM), as determined by SELEX with recombinant PUM2 PUM-HD protein.\",\n      \"method\": \"SELEX (iterative amplification-selection), recombinant protein binding assay\",\n      \"journal\": \"RNA\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro binding assay with purified recombinant domain, quantitative Kd measurement\",\n      \"pmids\": [\"11780640\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Human PUM2 specifically binds the Drosophila Nanos Response Element (NRE); single nucleotide changes abolish binding. PUM2 and DAZL co-immunoprecipitate and can bind the same RNA targets, including the 3'UTR of human SDAD1 mRNA.\",\n      \"method\": \"Co-immunoprecipitation, RNA binding assays, mutational analysis of NRE\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct binding assays with mutagenesis plus reciprocal co-IP\",\n      \"pmids\": [\"15607425\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Human BOULE (BOL) forms homodimers and interacts with PUM2. BOL and PUM2 form a complex on a subset of PUM2 RNA targets distinct from targets bound by PUM2/DAZL, indicating that protein cofactors determine which RNA targets are bound by PUM2.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping, RNA binding assays\",\n      \"journal\": \"Molecular reproduction and development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP with domain mapping, single lab\",\n      \"pmids\": [\"15806553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"PUM2 binds the 3'UTR of P2P-R mRNA via PUM2-binding elements (one perfect and two near-perfect PBEs), as confirmed by PUM2 pull-down combined with RT-PCR, suggesting PUM2-mediated translational regulation of P2P-R.\",\n      \"method\": \"RNA pull-down, RT-PCR\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single pull-down method, moderate mechanistic follow-up\",\n      \"pmids\": [\"15617101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PUM2 physically binds the D-box of Aurora-A kinase, protects Aurora-A from APC/C(Cdh1)-mediated ubiquitination and proteasomal degradation, and enhances Aurora-A kinase activity. In interphase, PUM2 is cytoplasmic and acts as a translational repressor; in mitosis, PUM2 translocates to centrosomes to stabilize and activate Aurora-A.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, kinase activity assay, overexpression/depletion, immunofluorescence localization\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal assays (co-IP, ubiquitination, kinase activity, localization) in single study\",\n      \"pmids\": [\"21589936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PUM2 inhibits translation of Mff (mitochondrial fission factor) mRNA, impairing mitochondrial fission and mitophagy. PUM2 levels increase with aging; CRISPR/Cas9-mediated Pum2 knockout in elderly mouse muscles enhances mitochondrial fission and mitophagy, improving mitochondrial quality control.\",\n      \"method\": \"Multi-omics, translational repression assays, CRISPR/Cas9 knockout in mice, cross-species (C. elegans puf-8 knockdown)\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multi-omics plus in vivo genetic KO with defined molecular and cellular phenotype, replicated cross-species\",\n      \"pmids\": [\"30642763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PUM1 and PUM2 repress translation of Cdkn1b (p27) by binding PBEs in its 3'UTR, promoting G1-S transition and cell proliferation, thereby controlling mouse body and organ size. Auto-regulatory and reciprocal post-transcriptional repression between Pum1 and Pum2 contributes to tissue-specific size control.\",\n      \"method\": \"Reporter assays (3'UTR luciferase), genetic null mouse models, epistasis (Cdkn1b deficiency rescue), cell proliferation assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reporter assays plus multiple genetic null mouse models and epistasis\",\n      \"pmids\": [\"30811992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Pum2 is restricted to the soma of developing neurons and retains PBE-containing mRNAs in the cell body, preventing their transport into axons. Pum2 knockdown causes PBE-containing mRNAs to appear and be translated in axons, and Pum2-deficient neurons exhibit axon growth, branching, and regeneration defects.\",\n      \"method\": \"Knockdown (shRNA), live-cell imaging, mRNA localization assays, in vivo axon branching analysis, axon regeneration assay\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KD with direct localization experiment tied to functional consequence, replicated in vivo and in vitro\",\n      \"pmids\": [\"31606248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PUM2 directly binds the 3'UTR of JAK2 and RUNX2 mRNAs and represses their translation. PUM2 depletion blocks MSC adipogenesis and enhances osteogenesis; Pum2 CRISPR knockdown in zebrafish inhibits lipid accumulation and induces bone formation.\",\n      \"method\": \"3'UTR reporter assays, RNA immunoprecipitation, CRISPR/Cas9 knockdown in zebrafish, differentiation assays\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct binding assay plus in vivo genetic model with defined phenotype\",\n      \"pmids\": [\"31595981\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PUM2 cooperativity in binding multiple PBE sites is mediated by RNA structure rather than direct protein-protein interactions; binding of one PUM2 molecule redistributes RNA conformational states to modulate access to additional PBE sites (positive or negative cooperativity depending on structural stability).\",\n      \"method\": \"Equilibrium binding measurements on 68 synthetic RNAs, statistical mechanical modeling, two-temperature analysis\",\n      \"journal\": \"RNA\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative in vitro binding assays across 68 RNA constructs with modeling\",\n      \"pmids\": [\"30914482\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PUM2 (but not PUM1) requires PBEs for repression of SIAH1 3'UTR-dependent reporter expression, whereas PUM1 exhibits PBE-independent repression. NANOS3 directly binds SIAH1 3'UTR independently of PBEs or the PUF domain, cooperating with PUM proteins in mRNA regulation.\",\n      \"method\": \"Luciferase reporter assays, EMSA, mutational analysis of PBEs\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — direct binding (EMSA) plus reporter mutagenesis, single lab\",\n      \"pmids\": [\"30269240\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PUM2 competitively binds to STARD13 3'UTR with miR-590-3p and miR-9, as shown by RIP-seq and luciferase reporter assays. PUM2 overexpression inhibits osteosarcoma cell proliferation, migration, and stemness via this mechanism.\",\n      \"method\": \"RNA immunoprecipitation combined with RNA sequencing, luciferase reporter assay, cell functional assays\",\n      \"journal\": \"Cell proliferation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — RIP-seq plus reporter assay, single lab\",\n      \"pmids\": [\"30084199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SUMOylation of PUM2 by UBE2I/SUMO2/3 decreases PUM2 protein stability and reduces PUM2's inhibitory effect on CEBPD mRNA, leading to upregulation of CEBPD and downstream DSG2, which promotes glioma vasculogenic mimicry.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence, RIP assay, ChIP assay, luciferase assay, cell invasion/migration assays\",\n      \"journal\": \"Clinical and translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP for SUMOylation plus RIP for RNA binding, single lab with multiple methods\",\n      \"pmids\": [\"32997416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Pum2 mediates decay of Sirt1 mRNA via binding to two PBEs in the Sirt1 3'UTR. Pum2-mediated Sirt1 mRNA decay promotes LKB1 acetylation and represses AMPK pathway activity, contributing to cardiomyocyte apoptosis in hypoxia/reoxygenation injury.\",\n      \"method\": \"3'UTR binding assay, overexpression/knockdown, Western blot for AMPK pathway, apoptosis assays\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct binding mapped to PBEs, pathway functional readout, single lab\",\n      \"pmids\": [\"32437714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Pum2 overexpression reduces Mff protein levels (without affecting mRNA) and preserves mitochondrial homeostasis in acute ischemic kidney injury, confirming the Pum2-Mff post-transcriptional axis in renal tubular cells.\",\n      \"method\": \"Western blot, overexpression in murine ischemia model, mitochondrial functional assays\",\n      \"journal\": \"Cell biology and toxicology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic manipulation with defined molecular and cellular phenotype, single lab\",\n      \"pmids\": [\"31993882\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Pum2 directly interacts with and affects the translation (but not mRNA levels or splicing) of Sox5, Bcl11b/Ctip2, and Rorβ mRNAs in mouse neocortical neurons, regulating area-specific cytoarchitecture and subcerebral connectivity.\",\n      \"method\": \"Transfection of primary neurons, in utero electroporation, retrograde labeling, single-molecule FISH, qRT-PCR, Pum2-Emx1-Cre conditional KO mice\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct binding plus in vivo conditional KO with cellular and circuit-level phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"35262486\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PUM2 directly binds DLX5 mRNA and represses its translation; PUM2 knockdown upregulates DLX5 expression and enhances osteogenic differentiation of mesenchymal stem cells.\",\n      \"method\": \"RNA immunoprecipitation, 3'UTR reporter assay, osteogenic differentiation assay, rat calvarial defect model\",\n      \"journal\": \"Journal of biomedical science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct RIP plus reporter assay with in vivo functional model, single lab\",\n      \"pmids\": [\"37088847\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PUM2 and PUM1 form distinct RNP regulatory networks in human male germ cells (TCam-2), associating with different protein cofactors (identified by mass spectrometry) and partially non-overlapping mRNA targets (identified by RIP-Seq), indicating functional divergence between paralogs.\",\n      \"method\": \"RIP-Seq, RNA-Seq, mass spectrometry-based interactome profiling\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — global MS interactome plus RIP-Seq, single lab\",\n      \"pmids\": [\"32316190\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"LncRNA circ_0075932 binds directly to PUM2 protein; PUM2 positively regulates AuroraA kinase, which activates the NF-κB pathway to promote inflammation and apoptosis in dermal keratinocytes downstream of adipocyte-derived exosomes.\",\n      \"method\": \"RNA-protein direct binding assay, siRNA knockdown, NF-κB pathway assays, cell apoptosis/inflammation assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single binding assay, pathway inference from knockdown\",\n      \"pmids\": [\"30824182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PUM2 mediates packaging of miR-130a into exosomes in cancer-associated fibroblasts; overexpression/knockdown of PUM2 correspondingly promotes/inhibits exosomal miR-130a loading and xenograft tumor growth.\",\n      \"method\": \"Overexpression, knockdown, exosome isolation, miRNA quantification, xenograft mouse model\",\n      \"journal\": \"International journal of nanomedicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — functional assay without direct molecular mechanism for packaging\",\n      \"pmids\": [\"33542625\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PUM2 suppresses SIRT1 expression, which in turn inhibits SLC7A11 expression, thereby aggravating ferroptosis and neuroinflammation in cerebral ischemia-reperfusion injury.\",\n      \"method\": \"RT-qPCR, Western blot, knockdown in MCAO mouse model and OGD/R cell model, rescue assays\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — pathway placement by knockdown/rescue without direct binding validation for SIRT1 target\",\n      \"pmids\": [\"35997855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PUM2 binds EFEMP1 mRNA via immunoprecipitation and promotes EFEMP1 expression (stabilization), inhibiting vascular smooth muscle cell phenotypic switching (proliferation/migration) and preventing aortic dissection in an Ang-II mouse model.\",\n      \"method\": \"Immunoprecipitation of RNA, Western blot, overexpression vectors, Ang-II mouse model, immunofluorescence\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct RNA-IP plus in vivo model, single lab\",\n      \"pmids\": [\"37062520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PUM2 facilitates degradation of NEDD4 mRNA by binding its 3'UTR, which prevents NEDD4-mediated ubiquitination and degradation of PTEN, thereby increasing PTEN levels and promoting chondrocyte ferroptosis through the Nrf2/HO-1 pathway.\",\n      \"method\": \"RNA immunoprecipitation, 3'UTR binding assay, Western blot, knockdown/overexpression, DMM mouse OA model\",\n      \"journal\": \"Environmental toxicology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct RIP binding plus in vivo model and pathway rescue experiments, single lab\",\n      \"pmids\": [\"38733337\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SENP1 directly deSUMOylates PUM2 (confirmed by Ni2+-NTA pull-down and co-IP), thereby enhancing PUM2 stability and expression. Stabilized PUM2 binds the 3'UTR of NRF2 mRNA, reducing NRF2 levels and diminishing transcriptional activation of HK1 and GLUT1, reducing glycolytic function in astrocytes.\",\n      \"method\": \"Ni2+-NTA agarose pull-down, co-immunoprecipitation, 3'UTR binding assay, APP/PS1 transgenic mouse model, knockdown rescue\",\n      \"journal\": \"Cell biology and toxicology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — direct deSUMOylation confirmed biochemically plus RNA binding and in vivo genetic model, single lab\",\n      \"pmids\": [\"39794619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PUM2-mediated repression of target mRNAs requires the CCR4-NOT deadenylase and is dependent on poly(A)-binding proteins PABPC1 and PABPC4; PUM2 associates with PABPCs, and increasing PABPC concentration inhibits PUM activity by stabilizing poly(A) tails.\",\n      \"method\": \"mRNA stability assays, co-immunoprecipitation of PUM with PABPCs, deadenylase requirement assays, PABPC titration experiments\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple biochemical assays in single preprint study, not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.10.02.680050\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PUM2 directly binds conserved Pumilio response elements (PREs) in SARS-CoV-2 transcripts, as shown by interactome data and PRE analysis, but neither PUM1 nor PUM2 affects progeny virion production.\",\n      \"method\": \"High-throughput interactome analysis, PRE mapping, PUM depletion and viral replication assays\",\n      \"journal\": \"The Journal of general virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct RNA binding supported by interactome data and functional viral assays, single study\",\n      \"pmids\": [\"40956600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PUM2 directly binds the 3'UTR of FOXO3 mRNA and inhibits its expression, promoting chondrocyte apoptosis in osteoarthritis.\",\n      \"method\": \"RNA immunoprecipitation, RNA pull-down, luciferase reporter, overexpression/knockdown, flow cytometry\",\n      \"journal\": \"Heliyon\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct binding by multiple assays with functional readout, single lab\",\n      \"pmids\": [\"38356524\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PUM2 suppresses stability of HDAC9 mRNA via direct binding (RIP and pull-down), attenuating HDAC9 expression and thereby reducing oxidative stress and promoting autophagy in diabetic contrast-induced acute kidney injury.\",\n      \"method\": \"RNA immunoprecipitation, RNA pull-down, mRNA stability assay, overexpression/knockdown, mouse DM-CIAKI model\",\n      \"journal\": \"Diabetes & metabolism journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding by two methods plus in vivo model, single lab\",\n      \"pmids\": [\"40930160\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The lncRNA Norad sequesters Pum2 protein, reducing its ability to bind and repress Mff mRNA translation. After ischemia-reperfusion, decreased Pum2 levels and binding to Mff mRNA (alongside increased Norad-Pum2 binding) lead to increased Mff protein, mitochondrial fragmentation, and neuronal injury; Pum2 overexpression restores mitochondrial morphology and reduces infarct volume.\",\n      \"method\": \"RNA-protein binding assays, OGD/R cell model, MCAO/R mouse model, Pum2 overexpression via viral vector\",\n      \"journal\": \"Brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RNA-protein binding plus in vivo model with mechanistic and functional readout, single lab\",\n      \"pmids\": [\"39832611\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PUM2 is a sequence-specific RNA-binding protein (PUF family) that uses its C-terminal PUM-HD domain to bind Pumilio-binding elements (PBEs: UGUANAUA) in 3'UTRs of target mRNAs, recruiting the CCR4-NOT deadenylase complex (dependent on PABPC1/4) to repress translation and/or promote mRNA decay of targets including Mff, Cdkn1b, Sirt1, JAK2, RUNX2, DLX5, and others; it is regulated post-translationally by SUMOylation (which reduces its stability) and deSUMOylation by SENP1 (which enhances it), and has a moonlighting mitotic role in which it physically associates with Aurora-A kinase at centrosomes to protect it from APC/C(Cdh1)-mediated degradation and enhance its kinase activity, while also shaping axonal transcriptomes by retaining PBE-containing mRNAs in the neuronal soma and controlling mitochondrial dynamics, body size, and stem cell differentiation through its translational repressor activity.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PUM2 is a PUF-family sequence-specific RNA-binding protein that recognizes Pumilio-binding elements (PBEs/PREs; core motif UGUANAUA) in 3′UTRs of target mRNAs and represses their expression through translational inhibition and mRNA destabilization, thereby governing diverse processes including mitochondrial dynamics, cell cycle progression, body size control, stem cell differentiation, and neuronal circuit wiring. PUM2 represses targets such as Mff, Cdkn1b/p27, Sirt1, JAK2, RUNX2, DLX5, FOXO3, and NRF2 by recruiting the CCR4-NOT deadenylase complex in a PABPC1/PABPC4-dependent manner, while its target selectivity is modulated by cofactors including DAZL and BOULE and by the lncRNA NORAD, which sequesters PUM2 away from its mRNA targets [PMID:11780640, PMID:15607425, PMID:30642763, PMID:30811992, PMID:39832611, PMID:bio_10.1101_2025.10.02.680050]. PUM2 protein stability is regulated by SUMOylation (which promotes its degradation) and SENP1-mediated deSUMOylation (which stabilizes it), and PUM2 has a non-canonical mitotic role at centrosomes where it binds the D-box of Aurora-A kinase, protecting it from APC/C(Cdh1)-dependent ubiquitination and enhancing its kinase activity [PMID:32997416, PMID:39794619, PMID:21589936]. In neurons, PUM2 localizes to the soma and retains PBE-containing mRNAs in the cell body, controlling axonal transcriptome composition and thereby regulating axon growth, branching, and cortical cytoarchitecture [PMID:31606248, PMID:35262486].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"The fundamental RNA-recognition specificity of PUM2 was established: PUM2's C-terminal PUM-HD binds a defined PBE consensus (UGUANAUA) with nanomolar affinity, defining it as a sequence-specific post-transcriptional regulator.\",\n      \"evidence\": \"SELEX with recombinant PUM2 PUM-HD and quantitative binding (Kd ~6.5 nM)\",\n      \"pmids\": [\"11780640\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No endogenous mRNA targets were identified at this stage\", \"No mechanism of repression (translational vs. decay) was determined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"PUM2 was shown to bind biologically relevant RNA targets (NRE, SDAD1 3′UTR) and to operate with distinct protein cofactors (DAZL, BOULE) that determine target selectivity, establishing PUM2 as a combinatorial RNP regulator rather than a standalone factor.\",\n      \"evidence\": \"Co-immunoprecipitation, RNA binding assays with mutagenesis, and domain mapping in human cell extracts\",\n      \"pmids\": [\"15607425\", \"15806553\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How cofactors alter RNA target selection was not mechanistically resolved\", \"In vivo significance of PUM2–DAZL and PUM2–BOULE complexes was not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"A non-canonical, RNA-independent role was discovered: PUM2 physically associates with Aurora-A kinase at centrosomes during mitosis, protects it from APC/C(Cdh1)-mediated degradation, and enhances its kinase activity, revealing a moonlighting function beyond translational repression.\",\n      \"evidence\": \"Co-IP, ubiquitination assays, kinase activity assays, and immunofluorescence localization in human cells\",\n      \"pmids\": [\"21589936\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PUM2's RNA-binding and Aurora-A stabilization functions are coordinated or independent was not resolved\", \"Structural basis of PUM2–D-box interaction was not determined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"PUM2 was established as a key post-transcriptional repressor controlling mitochondrial dynamics (via Mff), cell cycle/body size (via Cdkn1b), mesenchymal stem cell fate (via JAK2/RUNX2), and neuronal architecture (via somatic mRNA retention), demonstrating broad physiological relevance across tissues and organisms.\",\n      \"evidence\": \"CRISPR KO mice (Mff target), genetic null mouse models with epistasis (Cdkn1b), 3′UTR reporters and zebrafish knockdown (JAK2/RUNX2), shRNA knockdown with mRNA localization imaging and in vivo axon analysis (neuronal soma retention)\",\n      \"pmids\": [\"30642763\", \"30811992\", \"31595981\", \"31606248\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The deadenylase/decay machinery recruited by PUM2 was not yet identified\", \"How PUM2 physically retains mRNAs in the soma vs. repressing translation was not mechanistically distinguished\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Cooperativity in PUM2 binding to multi-PBE targets was shown to be RNA-structure-mediated rather than protein–protein-mediated, revealing that conformational redistribution of RNA upon PUM2 binding modulates access to additional sites.\",\n      \"evidence\": \"Quantitative equilibrium binding across 68 synthetic RNA constructs with statistical mechanical modeling\",\n      \"pmids\": [\"30914482\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RNA-structure-mediated cooperativity operates on endogenous mRNAs in vivo was not tested\", \"Effect on translational repression efficiency of cooperative vs. non-cooperative binding was not measured\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Post-translational regulation of PUM2 by SUMOylation was identified: SUMO2/3 conjugation reduces PUM2 stability, diminishing its repressive capacity on targets such as CEBPD, linking SUMO signaling to PUM2-dependent gene regulation.\",\n      \"evidence\": \"Co-IP for SUMOylation, RIP for RNA binding, luciferase reporters in glioma cells\",\n      \"pmids\": [\"32997416\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The E3 SUMO ligase responsible was not identified\", \"Whether SUMOylation directly alters RNA binding or only protein stability was not distinguished\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"PUM1 and PUM2 were shown to form distinct RNP complexes with partially non-overlapping interactomes and target mRNAs in human male germ cells, establishing functional divergence between the two paralogs.\",\n      \"evidence\": \"RIP-Seq and mass spectrometry interactome profiling in TCam-2 cells\",\n      \"pmids\": [\"32316190\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequences of paralog-specific targets were not tested\", \"Whether divergence is conserved across tissues was not assessed\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"PUM2's role in cortical development was refined: it directly binds and translationally represses Sox5, Bcl11b/Ctip2, and Rorβ mRNAs in neocortical neurons, shaping area-specific cytoarchitecture and subcerebral projection neuron identity in vivo.\",\n      \"evidence\": \"Conditional Pum2 KO (Emx1-Cre), single-molecule FISH, retrograde tracing, in utero electroporation in mouse cortex\",\n      \"pmids\": [\"35262486\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PUM2 controls these targets via deadenylation or translational initiation block was not determined\", \"Interaction with other RNA-binding proteins in cortical progenitors was not mapped\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"SENP1-mediated deSUMOylation was identified as the counterbalancing mechanism that stabilizes PUM2, and the downstream functional consequence was mapped: stabilized PUM2 represses NRF2 mRNA, reducing glycolytic gene expression in astrocytes.\",\n      \"evidence\": \"Ni²⁺-NTA pull-down and co-IP for deSUMOylation, 3′UTR binding assay, APP/PS1 transgenic mouse model\",\n      \"pmids\": [\"39794619\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether SENP1-PUM2 axis operates globally or only in astrocytes is unknown\", \"Quantitative relationship between SUMOylation state and PUM2 activity is not established\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"The effector mechanism of PUM2-mediated repression was identified: PUM2 recruits the CCR4-NOT deadenylase complex, and this repression requires and is antagonized by PABPC1/PABPC4 concentration, establishing PUM2 as a deadenylation-dependent repressor.\",\n      \"evidence\": \"(preprint) mRNA stability assays, co-IP of PUM2 with PABPCs, deadenylase requirement assays, PABPC titration\",\n      \"pmids\": [\"bio_10.1101_2025.10.02.680050\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Peer review pending\", \"Whether all PUM2 targets are repressed via deadenylation or some use a deadenylation-independent mechanism was not resolved\", \"Direct PUM2–CNOT subunit interaction was not mapped\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"The lncRNA NORAD was shown to act as a molecular sponge for PUM2, and ischemia-reperfusion shifts the NORAD–PUM2 equilibrium to de-repress Mff, causing mitochondrial fragmentation and neuronal injury — establishing NORAD as a physiological rheostat of PUM2 activity.\",\n      \"evidence\": \"RNA-protein binding assays, OGD/R cell model, MCAO/R mouse model with PUM2 viral overexpression\",\n      \"pmids\": [\"39832611\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether NORAD regulation of PUM2 is a general mechanism across tissues or restricted to ischemic neurons is not resolved\", \"Stoichiometry of NORAD–PUM2 interaction in physiological conditions is unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major unresolved questions include the structural basis of PUM2-mediated CCR4-NOT recruitment, the mechanism by which PUM2 retains mRNAs in the neuronal soma versus canonical translational repression, and whether SUMOylation/deSUMOylation regulates PUM2 activity genome-wide or in a target-specific manner.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No cryo-EM or structural model of PUM2 in complex with CCR4-NOT\", \"Mechanism of somatic mRNA retention versus translational silencing not distinguished\", \"Genome-wide impact of SUMO cycling on PUM2 target repertoire unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 1, 5, 7, 8, 9, 15, 25]},\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [5, 13, 22, 27]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [4, 6]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [5, 6, 7, 8, 15, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4, 7]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 5, 9, 13, 22, 24, 27]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [4, 12, 23, 24]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [4, 6]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [13, 26]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [7, 15]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [7, 15, 28]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"AURKA\",\n      \"DAZL\",\n      \"BOLL\",\n      \"PABPC1\",\n      \"PABPC4\",\n      \"SENP1\",\n      \"NANOS3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}